| 000 | 01700 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513212714.0 | ||
| 264 | 0 | _c20000919 | |
| 008 | 200009s 0 0 eng d | ||
| 022 | _a0340-6997 | ||
| 024 | 7 |
_a10.1007/s002590050535 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWichers, M | |
| 245 | 0 | 0 |
_aTesticular function after radioiodine therapy for thyroid carcinoma. _h[electronic resource] |
| 260 |
_bEuropean journal of nuclear medicine _cMay 2000 |
||
| 300 |
_a503-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarcinoma _xpathology |
| 650 | 0 | 4 |
_aCarcinoma, Papillary _xpathology |
| 650 | 0 | 4 |
_aCarcinoma, Papillary, Follicular _xpathology |
| 650 | 0 | 4 |
_aFollicle Stimulating Hormone _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInhibins _xblood |
| 650 | 0 | 4 |
_aIodine Radioisotopes _xadverse effects |
| 650 | 0 | 4 |
_aLeydig Cells _xradiation effects |
| 650 | 0 | 4 |
_aLuteinizing Hormone _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrgan Size _xradiation effects |
| 650 | 0 | 4 |
_aRadiotherapy _xadverse effects |
| 650 | 0 | 4 |
_aSpermatogenesis _xradiation effects |
| 650 | 0 | 4 |
_aSpermatozoa _xradiation effects |
| 650 | 0 | 4 |
_aTestis _xmetabolism |
| 650 | 0 | 4 |
_aTestosterone _xblood |
| 650 | 0 | 4 |
_aThyroid Neoplasms _xpathology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aBenz, E | |
| 700 | 1 | _aPalmedo, H | |
| 700 | 1 | _aBiersack, H J | |
| 700 | 1 | _aGrünwald, F | |
| 700 | 1 | _aKlingmüller, D | |
| 773 | 0 |
_tEuropean journal of nuclear medicine _gvol. 27 _gno. 5 _gp. 503-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002590050535 _zAvailable from publisher's website |
| 999 |
_c10804894 _d10804894 |
||